Tania Borja Rodriguez, NP

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Tania Borja Rodriguez’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Drugs they prescribed that Part D paid

$288,354

Pharmacies billed $288,354 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 1% of their Part D prescriptions (13 of 1,102) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

815 generic and 261 brand-name prescriptions · $288,354 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ozempic	48	$60,399	$1,258
Jardiance	44	$54,951	$1,249
Eliquis	32	$34,734	$1,085
Entresto	28	$30,305	$1,082
Vascepa	22	$8,074	$367

See all 27 drugs

Sort by

Every Part D drug this clinician prescribed

Ozempic	48	$60,399	$1,258
Jardiance	44	$54,951	$1,249
Eliquis	32	$34,734	$1,085
Entresto	28	$30,305	$1,082
Vascepa	22	$8,074	$367
Rosuvastatin	53	$1,412	$27
Metoprolol	45	$1,018	$23
Ezetimibe	27	$804	$30
Atorvastatin	65	$625	$10
Carvedilol	66	$429	$7
Losartan	50	$363	$7
Spironolactone	32	$287	$9
Amlodipine Besylate	45	$272	$6
Metformin	49	$234	$5
Pantoprazole	26	$223	$9
Valsartan	14	$201	$14
Pravastatin	13	$186	$14
Lisinopril	40	$185	$5
Isosorbide Mononitrate Er	12	$180	$15
Levothyroxine	12	$165	$14
Amiodarone	11	$128	$12
Clonidine	11	$124	$11
Clopidogrel	14	$102	$7
Furosemide	35	$89	$3
Chlorthalidone	18	$72	$4
Oxycodone	13	$36	$3
Potassium Chloride	11	$28	$3

Year by year

Sort by

Part D prescribing by year

2024	1,102	187	1% (13)	24%	$288,354
2023	949	195	1% (12)	24%	$281,894
2022	696	213	None	None	$137,077
2021	2,395	264	0% (0)	20%	$411,909
2020	3,190	264	0% (0)	21%	$512,598
2019	1,656	189	0% (0)	18%	$191,322

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 27 drugs

Sort by

Part D drugs prescribed in 2023

Jardiance	42	$59,160	$1,409
Entresto	34	$34,591	$1,017
Ozempic	26	$32,231	$1,240
Eliquis	27	$28,332	$1,049
Vascepa	19	$6,545	$344
Icosapent Ethyl	16	$4,300	$269
Rosuvastatin	41	$2,487	$61
Atorvastatin	67	$2,338	$35
Ezetimibe	24	$1,681	$70
Lisinopril	58	$867	$15
Metoprolol	28	$834	$30
Amlodipine Besylate	35	$790	$23
Losartan	38	$782	$21
Ultra-Fine Short Pen Needle	14	$684	$49
Carvedilol	37	$679	$18
Amiodarone	15	$459	$31
Clopidogrel	16	$431	$27
Spironolactone	27	$429	$16
Metformin	16	$391	$24
Levothyroxine	14	$360	$26
Chlorthalidone	13	$333	$26
Pantoprazole	32	$311	$10
Nitroglycerin	13	$231	$18
Potassium Chloride	21	$152	$7
Furosemide	27	$80	$3
Metoprolol	17	$68	$4
Oxycodone	11	$63	$6

2022: 19 drugs

Sort by

Part D drugs prescribed in 2022

Eliquis	23	$23,021	$1,001
Veltassa	12	$20,515	$1,710
Xarelto	14	$13,266	$948
Praluent	14	$7,928	$566
Vascepa	14	$5,479	$391
Colchicine	55	$3,624	$66
Rosuvastatin	43	$1,834	$43
Atorvastatin	35	$673	$19
Ezetimibe	16	$415	$26
Pantoprazole	49	$390	$8
Carvedilol	35	$390	$11
Amlodipine Besylate	37	$319	$9
Spironolactone	15	$276	$18
Losartan	22	$275	$12
Metoprolol	21	$267	$13
Lisinopril	23	$210	$9
Metformin	23	$116	$5
Cephalexin	19	$113	$6
Furosemide	12	$44	$4

2021: 42 drugs

Sort by

Part D drugs prescribed in 2021

Jardiance	57	$76,118	$1,335
Eliquis	48	$54,691	$1,139
Trulicity	29	$38,566	$1,330
Vascepa	75	$29,332	$391
Januvia	29	$26,501	$914
Entresto	21	$20,346	$969
Rybelsus	19	$18,419	$969
Ozempic	17	$15,315	$901
Xarelto	18	$15,252	$847
Veltassa	15	$14,714	$981
Praluent	20	$10,833	$542
Basaglar Kwikpen U-100	15	$10,432	$695
Farxiga	13	$10,105	$777
Lantus Solostar	11	$6,039	$549
Atorvastatin	259	$4,526	$17
Amiodarone	15	$3,732	$249
Metoprolol	128	$2,905	$23
Ranolazine Er	12	$2,571	$214
Ezetimibe	45	$2,365	$53
Rosuvastatin	59	$2,074	$35
Chlorthalidone	64	$1,792	$28
Carvedilol	157	$1,776	$11
Losartan	117	$1,599	$14
Diclofenac	55	$1,562	$28
Lisinopril	172	$1,103	$6
Pravastatin	43	$1,078	$25
Amlodipine Besylate	139	$1,070	$8
Isosorbide Mononitrate Er	45	$1,039	$23
Nitroglycerin	40	$757	$19
Nano 2nd Gen Pen Needle	15	$738	$49
Metformin	78	$534	$7
Levothyroxine	25	$519	$21
Famotidine	13	$452	$35
Furosemide	77	$362	$5
Spironolactone	48	$337	$7
Clopidogrel	29	$283	$10
Potassium Chloride	11	$255	$23
Pantoprazole	28	$223	$8
Warfarin	34	$223	$7
Hydralazine	12	$187	$16
Clonidine	25	$154	$6
Hydrochlorothiazide	14	$138	$10

2020: 51 drugs

Sort by

Part D drugs prescribed in 2020

Jardiance	78	$102,403	$1,313
Eliquis	67	$66,908	$999
Trulicity	50	$48,266	$965
Januvia	41	$39,255	$957
Ozempic	24	$27,008	$1,125
Victoza 3-Pak	19	$24,832	$1,307
Xarelto	37	$24,311	$657
Rybelsus	19	$19,798	$1,042
Vascepa	53	$16,998	$321
Veltassa	19	$16,959	$893
Entresto	11	$14,879	$1,353
Restasis	24	$14,093	$587
Praluent	13	$11,966	$920
Atorvastatin	340	$4,777	$14
Metoprolol	156	$4,105	$26
Chlorthalidone	64	$3,150	$49
Rosuvastatin	68	$2,868	$42
Ezetimibe	81	$2,437	$30
Losartan	155	$2,078	$13
Lisinopril	290	$1,844	$6
Ranolazine Er	15	$1,676	$112
Diclofenac	58	$1,619	$28
Fluticasone-Salmeterol	15	$1,546	$103
Carvedilol	191	$1,274	$7
Amlodipine Besylate	189	$1,077	$6
Pen Needles	14	$1,021	$73
Albuterol Sulfate Hfa	17	$957	$56
Pravastatin	37	$844	$23
Isosorbide Mononitrate Er	49	$829	$17
Potassium Chloride	22	$766	$35
Ventolin Hfa	13	$752	$58
Spironolactone	79	$698	$9
Warfarin	75	$697	$9
Nitroglycerin	48	$666	$14
Fenofibrate	14	$535	$38
Levothyroxine	23	$495	$22
Furosemide	105	$477	$5
Metformin	75	$450	$6
Clonidine	41	$447	$11
Ultra-Fine Short Pen Needle	11	$416	$38
Propafenone	17	$348	$20
Cilostazol	11	$308	$28
Hydralazine	23	$282	$12
Famotidine	24	$230	$10
Montelukast	13	$196	$15
Meclizine	11	$152	$14
Clopidogrel	18	$120	$7
Pantoprazole	13	$77	$6
Hydrochlorothiazide	13	$70	$5
Alcohol Prep Pads	13	$68	$5
Atenolol	11	$40	$4

2019: 29 drugs

Sort by

Part D drugs prescribed in 2019

Jardiance	42	$61,834	$1,472
Januvia	19	$16,780	$883
Victoza 3-Pak	13	$11,467	$882
Eliquis	15	$10,358	$691
Victoza 2-Pak	11	$9,228	$839
Advair Diskus	16	$5,481	$343
Atorvastatin	192	$3,185	$17
Chlorthalidone	58	$3,030	$52
Metoprolol	64	$2,469	$39
Ezetimibe	28	$1,786	$64
Rosuvastatin	33	$1,744	$53
Fluticasone-Salmeterol	12	$1,444	$120
Carvedilol	136	$1,321	$10
Diclofenac	27	$940	$35
Lisinopril	133	$934	$7
Pravastatin	22	$860	$39
Warfarin	76	$793	$10
Amlodipine Besylate	119	$741	$6
Isosorbide Mononitrate Er	29	$727	$25
Spironolactone	59	$686	$12
Losartan	65	$625	$10
Nitroglycerin	24	$623	$26
Famotidine	38	$504	$13
Clonidine	28	$408	$15
Potassium Chloride	12	$351	$29
Furosemide	55	$338	$6
Cilostazol	14	$326	$23
Metformin	19	$128	$7
Clopidogrel	14	$105	$8

Money from drug and device companies

$384 in 2025

Sort by

Industry payments by year

2025	2	3	None	$384
2024	2	3	None	$138
2022	2	2	None	$321
2021	8	14	None	$270

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

AtriCure	Atricure Cryoice Cryosphere Cryoablation System	$259	2 payments Meals for Atricure Cryoice Cryosphere Cryoablation System · 2025-07-09 · $19 Meals for Atricure Cryoice Cryosphere Cryoablation System · 2025-07-09 · $240
Mayne Pharma Commercial	Annovera	$125	1 payment Meals for Annovera · 2025-02-13 · $125

See all 3 published payments

Sort by

Every published payment

AtriCure	Meals · 2025-07-09	Atricure Cryoice Cryosphere Cryoablation System	$19
AtriCure	Meals · 2025-07-09	Atricure Cryoice Cryosphere Cryoablation System	$240
Mayne Pharma Commercial	Meals · 2025-02-13	Annovera	$125

See earlier years (2024, 2022, 2021)

2024: $138

Sort by

Payments by company in 2024

Shield Therapeutics	Accrufer	$124	2 payments Meals for Accrufer · 2024-01-18 · $62 Meals for Accrufer · 2024-01-18 · $62
AstraZeneca Pharmaceuticals LP	Farxiga	$14	1 payment Meals for Farxiga · 2024-07-25 · $14

2022: $321

Sort by

Payments by company in 2022

AtriCure	Epi-Sense Guided Coagulation System With Visitrax	$294	1 payment Travel for Epi-Sense Guided Coagulation System With Visitrax · 2022-07-22 · $294
Biotronik	Biomonitor	$27	1 payment Meals for Biomonitor · 2022-12-06 · $27

2021: $270

Sort by

Payments by company in 2021

Boehringer Ingelheim Pharmaceuticals	Jardiance	$60	2 payments Meals for Jardiance · 2021-05-05 · $31 Meals for Jardiance · 2021-02-17 · $28
Merck Sharp & Dohme	Januvia	$58	3 payments Meals for Januvia · 2021-05-04 · $22 Meals for Januvia · 2021-03-08 · $16 Meals for Januvia · 2021-02-01 · $19
Novo Nordisk	Ozempic	$51	3 payments Meals for Ozempic · 2021-03-31 · $13 Meals for Ozempic · 2021-03-20 · $19 Meals for Ozempic · 2021-02-19 · $18
Amarin Pharma	Vascepa	$34	2 payments Meals for Vascepa · 2021-03-23 · $18 Meals for Vascepa · 2021-03-02 · $16
Kiniksa Pharmaceuticals	None	$20	1 payment Meals · 2021-04-20 · $20
Esperion Therapeutics	Nexletol	$18	1 payment Meals for Nexletol · 2021-03-22 · $18
AstraZeneca Pharmaceuticals LP	Brilinta	$18	1 payment Meals for Brilinta · 2021-02-02 · $18
Biotronik	Rivacor	$13	1 payment Education for Rivacor · 2021-01-05 · $13

Checkups this office reported

2023

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 83.6 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

What the office says it does

Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.

Improved the patient portal
Lets patients read their visit notes
Uses standard treatment protocols

Professional record

NPI: 1437623253
Licence: CA NP95010411
Group: Stanford Health Care
Gender: Female

More record details

Sole proprietor: Yes
Taxonomy: Nurse practitioner (363L00000X); Federal specialty code 363LF0000X (363LF0000X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2019-01-15
NPI last updated: 2023-02-06
NPI record certified: 2023-02-06

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 334 Via Vera Cruz #257, San Marcos, CA, 92078